Latest / Decera Clinical Education Oncology Podcast
Immunotherapy for Advanced HCC: Current Options and Expert Answers to Clinician Questions
In this episode, David Kaplan, MD, MSc, and Thomas Karasic, MD, review approved immunotherapy options for advanced HCC and answer key questions surrounding use of immune checkpoint inhibitors, with topics including:
Current systemic therapy standards of care for patients with advanced HCC
Use of single-agent immune checkpoint inhibitor therapy in the first-line setting
Assessing bleeding risk
Using immunotherapy in patients with active HBV or HCV infections
Presenters:
David Kaplan, MD, MSc
Associate Professor
Perelman School of Medicine
University of Pennsylvania
Director of Hepatology…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.